Mechanisms of a Mycobacterium tuberculosis Active Peptide
Multidrug-resistant tuberculosis (MDR) continues to pose a threat to public health. Previously, we identified a cationic host defense peptide with activity against in vivo and with a bactericidal effect against MDR at therapeutic concentrations. To understand the mechanisms of this peptide, we inves...
Saved in:
Published in | Pharmaceutics Vol. 15; no. 2; p. 540 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Switzerland
MDPI AG
06.02.2023
MDPI |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Multidrug-resistant tuberculosis (MDR) continues to pose a threat to public health. Previously, we identified a cationic host defense peptide with activity against
in vivo and with a bactericidal effect against MDR
at therapeutic concentrations. To understand the mechanisms of this peptide, we investigated its interactions with live
and liposomes as a model. Peptide interactions with
inner membranes induced tube-shaped membranous structures and massive vesicle formation, thus leading to bubbling cell death and ghost cell formation. Liposomal studies revealed that peptide insertion into inner membranes induced changes in the peptides' secondary structure and that the membranes were pulled such that they aggregated without permeabilization, suggesting that the peptide has a strong inner membrane affinity. Finally, the peptide targeted essential proteins in
, such as 60 kDa chaperonins and elongation factor Tu, that are involved in mycolic acid synthesis and protein folding, which had an impact on bacterial proliferation. The observed multifaceted targeting provides additional support for the therapeutic potential of this peptide. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 1999-4923 1999-4923 |
DOI: | 10.3390/pharmaceutics15020540 |